Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 65862-783

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 65862-783). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)

Figure 3: Maintenance Of Healing Rates By Month (study 178) (Esomeprazole Fig1)
A line graph showing the percent maintained of Esomeprazole Magnesium at 40 mg, 20 mg, and 10 mg dosages compared to placebo over a 6-month period with scheduled visits indicated. The graph plots percent maintained on the vertical axis and months on the horizontal axis, illustrating treatment effects over time.*
FDA Label Image

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)

Figure 2: Maintenance Of Healing Rates By Month (study 177) (Esomeprazole Fig2)
A line graph showing the percentage maintained over months for different treatments: Esomeprazole Magnesium 40 mg, 20 mg, 10 mg, and placebo. The x-axis represents months with scheduled visit points, while the y-axis shows percent maintained. The graph includes a legend with sample sizes for each group.*
FDA Label Image

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)

Figure 4: Percent Of Patients Symptom-free Of Heartburn By Day (study 225) (Esomeprazole Fig3)
A line graph showing the percent of patients symptom-free over a 28-day diary period comparing Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses versus a placebo. The percent symptom-free increases over time with both doses, consistently higher than placebo across days.*
FDA Label Image

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)

Figure 5: Percent Of Patients Symptom-free Of Heartburn By Day (study 226) (Esomeprazole Fig4)
A line graph charting the percent of patients symptom-free over a 28-day diary period. It compares Esomeprazole Magnesium delayed-release capsules at 40 mg and 20 mg doses against a placebo, tracking symptom-free rates across days from 0 to 28.*
FDA Label Image

Package Label-principal Display Panel (20 mg (30 Capsules Bottle))

Package Label-principal Display Panel (20 mg (30 Capsules Bottle))
Label for Esomeprazole Magnesium Delayed-Release Capsules USP 20 mg by Aurobindo Pharma Limited. The label indicates a package of 30 capsules with storage instructions at 20° to 25°C. It includes distributor information for Aurobindo Pharma USA, Inc., and specifies the product is made in India. The label also mentions the patient medication guide for pharmacists.*
FDA Label Image

Package Label-principal Display Panel (20 MG (10 X 10) UNIT-DOSE CAPSULES)

Package Label-principal Display Panel (20 MG (10 X 10) UNIT-DOSE CAPSULES)
Packaging label for Esomeprazole Magnesium Delayed-Release Capsules USP 20 mg by Aurobindo Pharma Limited. The label indicates 100 (10 x 10) unit-dose capsules. It includes storage instructions, a barcode, a pharmacist dispensing note, and distributor information for Aurobindo Pharma USA, Inc. The capsules are identified as prescription only.*
FDA Label Image

Package Label-principal Display Panel (40 MG (30 CAPSULES BOTTLE))

Package Label-principal Display Panel (40 MG (30 CAPSULES BOTTLE))
Label for Esomeprazole Magnesium Delayed-Release Capsules USP 40 mg by Aurobindo Pharma Limited. The label specifies each delayed-release capsule contains esomeprazole magnesium dihydrate USP equivalent to 40 mg esomeprazole. It includes storage instructions, distributor information (Aurobindo Pharma USA, Inc.), NDC 65862-784-30, and a barcode. The package contains 30 capsules.*
FDA Label Image

Package Label-principal Display Panel (40 MG (10 X 10) UNIT-DOSE CAPSULES)

Package Label-principal Display Panel (40 MG (10 X 10) UNIT-DOSE CAPSULES)
Packaging label for Esomeprazole Magnesium Delayed-Release Capsules USP, 40 mg, manufactured by Aurobindo Pharma Limited and distributed by Aurobindo Pharma USA, Inc. The package contains 100 unit-dose capsules. The label includes storage instructions, dosage form, and a barcode on a white background with green and blue design elements.*
FDA Label Image

Chemical Structure (Esomeprazole Str)

Chemical Structure (Esomeprazole Str)
Chemical structure diagram of Esomeprazole Magnesium showing the molecular components including methoxy, methyl, sulfoxide groups, and magnesium ion complex.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.